During the past decade, Itabashi Chuo Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Itabashi Chuo Medical Center" are "Cervical Ripening" (2 trials), "Ischemic Heart Disease" (1 trials), "Long Coronary Artery Disease" (1 trials), "Restenosis" (1 trials) and "Stable Angina Pectoris" (1 trials). Many other conditions were trialed in "Itabashi Chuo Medical Center" in a lesser frequency.

Most popular intervention types in "Itabashi Chuo Medical Center" are "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dinoprostone" (2 trials), "Intracoronary stent implantation" (1 trials), "Paclitaxel-eluting stent (TAXUS)" (1 trials), "Placebo" (1 trials) and "Sirolimus-eluting coronary stent (Cypher)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Itabashi Chuo Medical Center" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Itabashi Chuo Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Itabashi Chuo Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Itabashi Chuo Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".